Literature DB >> 23332598

CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem.

Luigi Racioppi1.   

Abstract

The androgen receptor (AR) is pivotal in the biology of sex hormone-regulated malignancies, with prostate cancer (PC) the most affected tumor. AR signals control the growth, survival, and migration of cancer cells, and they regulate the activation of macrophages, a cell type pivotal to the tumor ecosystem. Intriguingly, CaMKK2 has recently been identified as both an important AR-regulated gene in the context of PC and as a critical regulator of macrophage activation. By contrast, CaMKK2 is barely detectable in normal prostate or immune cells that mediate the response against tumorigenesis. These novel findings suggest that CaMKK2 resides at a critical molecular node that shapes the cancer ecosystem, and identifies this kinase as a novel therapeutic target for sex hormone-regulated cancers.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332598      PMCID: PMC3565098          DOI: 10.1016/j.molmed.2012.12.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  71 in total

1.  The program of androgen-responsive genes in neoplastic prostate epithelium.

Authors:  Peter S Nelson; Nigel Clegg; Hugh Arnold; Camari Ferguson; Michael Bonham; James White; Leroy Hood; Biaoyang Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-16       Impact factor: 11.205

Review 2.  TLR signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Semin Immunol       Date:  2007-02-01       Impact factor: 11.130

3.  A cell-intrinsic role for CaMKK2 in granulocyte lineage commitment and differentiation.

Authors:  Ellen C Teng; Luigi Racioppi; Anthony R Means
Journal:  J Leukoc Biol       Date:  2011-08-04       Impact factor: 4.962

4.  Transient P2X7 receptor activation triggers macrophage death independent of Toll-like receptors 2 and 4, caspase-1, and pannexin-1 proteins.

Authors:  Peter J Hanley; Moritz Kronlage; Carsten Kirschning; Adriana del Rey; Francesco Di Virgilio; Jens Leipziger; Iain P Chessell; Sarah Sargin; Mikhail A Filippov; Otto Lindemann; Simon Mohr; Volker Königs; Hermann Schillers; Martin Bähler; Albrecht Schwab
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

Review 5.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

6.  Calcium responses elicited by nucleotides in macrophages. Interaction between two receptor subtypes.

Authors:  S R Alonso-Torre; A Trautmann
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

7.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

Review 8.  Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller.

Authors:  Luigi Racioppi; Anthony R Means
Journal:  Trends Immunol       Date:  2008-10-17       Impact factor: 16.687

9.  Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling.

Authors:  Mario Galgani; Veronica De Rosa; Salvatore De Simone; Antonio Leonardi; Ugo D'Oro; Giorgio Napolitani; Anna Maria Masci; Serafino Zappacosta; Luigi Racioppi
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

10.  Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2.

Authors:  Maria Høyer-Hansen; Lone Bastholm; Piotr Szyniarowski; Michelangelo Campanella; György Szabadkai; Thomas Farkas; Katiuscia Bianchi; Nicole Fehrenbacher; Folmer Elling; Rosario Rizzuto; Ida Stenfeldt Mathiasen; Marja Jäättelä
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

View more
  15 in total

1.  MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.

Authors:  Hao Fu; Hui-chan He; Zhao-dong Han; Yue-ping Wan; Hong-wei Luo; Ya-qiang Huang; Chao Cai; Yu-xiang Liang; Qi-shan Dai; Fu-neng Jiang; Wei-de Zhong
Journal:  Tumour Biol       Date:  2014-11-15

2.  Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells.

Authors:  Yuyang Sun; Pramod Sukumaran; Archana Varma; Susan Derry; Abe E Sahmoun; Brij B Singh
Journal:  Biochim Biophys Acta       Date:  2014-04-25

3.  CaMKII plays a part in the chondrogenesis of bone marrow-derived mesenchymal stem cells.

Authors:  Feng Qu; Zhikun Zhao; Bangtuo Yuan; Wei Qi; Chunbao Li; Xuezhen Shen; Chang Liu; Hongliang Li; Gang Zhao; Jiangtao Wang; Qi Guo; Yujie Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Nazia Syed; Mustafa A Barbhuiya; Remya Raja; Arivusudar Marimuthu; Nandini Sahasrabuddhe; Sneha M Pinto; Srikanth Srinivas Manda; Santosh Renuse; H C Manju; Mohammed Abdul Lateef Zameer; Jyoti Sharma; Mariana Brait; Kotteazeth Srikumar; Juan Carlos Roa; M Vijaya Kumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha Vijay Kumar; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Bioinformatics analysis identifies potential chemoresistance-associated genes across multiple types of cancer.

Authors:  Jingsheng Yuan; Lulu Tan; Zhijie Yin; Kaixiong Tao; Guobing Wang; Wenjia Shi; Jinbo Gao
Journal:  Oncol Lett       Date:  2019-06-27       Impact factor: 2.967

6.  A complete map of the Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) signaling pathway.

Authors:  Mohd Altaf Najar; D A B Rex; Prashant Kumar Modi; Nupur Agarwal; Shobha Dagamajalu; Gayathree Karthikkeyan; Manavalan Vijayakumar; Aditi Chatterjee; Uma Sankar; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

7.  Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer.

Authors:  Thomas L Pulliam; Dominik Awad; Jenny J Han; Mollianne M Murray; Jeffrey J Ackroyd; Pavithr Goli; Jonathan S Oakhill; John W Scott; Michael M Ittmann; Daniel E Frigo
Journal:  Cells       Date:  2022-06-10       Impact factor: 7.666

Review 8.  Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.

Authors:  Ji Cheng; Tao Zhang; Hongbin Ji; Kaixiong Tao; Jianping Guo; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-09-25

9.  Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.

Authors:  Suhn Kyong Rhie; Yu Guo; Yu Gyoung Tak; Lijing Yao; Hui Shen; Gerhard A Coetzee; Peter W Laird; Peggy J Farnham
Journal:  Epigenetics Chromatin       Date:  2016-11-09       Impact factor: 4.954

10.  Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.

Authors:  Niall M Corcoran; Anthony T Papenfuss; Christopher M Hovens; Stefano Mangiola; Patrick McCoy; Martin Modrak; Fernando Souza-Fonseca-Guimaraes; Daniel Blashki; Ryan Stuchbery; Simon P Keam; Michael Kerger; Ken Chow; Chayanica Nasa; Melanie Le Page; Natalie Lister; Simon Monard; Justin Peters; Phil Dundee; Scott G Williams; Anthony J Costello; Paul J Neeson; Bhupinder Pal; Nicholas D Huntington
Journal:  BMC Cancer       Date:  2021-07-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.